Cooper Companies (The)

(In millions, except per share data)

(Unaudited)

| | | | | | | | | | | |
| | July 31, 2026 | | October 31, 2025
| ASSETS | | |
| Current assets: | | |
| Cash and cash equivalents | $ | 154.7 | | | $ | 110.6 |
|

Trade accounts receivable, net of allowance for credit losses of $76.1 at July 31, 2026, and $51.9 at October 31, 2025

| 788.9 | | | 829.0 |

(in millions)

|

August 1, 2025 to August 31, 2025

| | 399.4 | | | $ | 65.68 | | | 399.4 | | | $ | 137.4 |
|

September 1, 2025 to September 30, 2025

| | 2,006.2 | | | $ | 67.08 | | | 2,006.2 | | | $ | 1,002.8 |
|

October 1, 2025 to October 31, 2025

| | 517.9 | | | $ | 70.40 | | | 517.9 | | | $ | 966.4 |
|

Total

| | 2,923.5 | | | $ | 67.48 | | | 2,923.5 | | |

Unregistered Sales of Equity Securities

None.

A multiyear implementation of new ERP systems at CooperVision and CooperSurgical is costly, complex and difficult and may negatively affect financial accounting and reporting and external commercial activities such as order receipt and product delivery.

Additional material weaknesses in the future could impair accurate recording, processing and reporting and timely financial statement preparation and could lead to litigation, investigations, reputational harm, legal claims or proceedings, regulatory investigations and enforcement actions, significant remedial costs, additional management resources and legal expenses, lower investor confidence and stock price declines.

Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are:

•Adverse changes in the global or regional general business, political and economic conditions, including the impact of continuing uncertainty and instability of certain countries, man-made or natural disasters and pandemic conditions, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items.

•The impact of international conflicts, including the ongoing conflict in the Middle East, and the global response to international conflicts on the global and local economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, or around, affected countries.

•Our substantial and expanding international operations and the challenges of managing an organization spread throughout multiple countries and complying with a variety of legal, compliance and regulatory requirements.

•The actual imposition or threats of tariffs, customs duties and fees by the U.S. government and other nations in response and other retaliatory actions, such as trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers, as well as the impact of the Company’s efforts to mitigate the effects of such tariffs or similar measures.

•Foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings.

•Our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds.

•Changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income.

•Acquisition-related adverse effects including the failure to successfully achieve the anticipated net sales, margins and earnings benefits of acquisitions, integration delays or costs and the requirement to record significant adjustments to the preliminary fair value of assets acquired and liabilities assumed within the measurement period, required regulatory approvals for an acquisition not being obtained or being delayed or subject to conditions that are not anticipated, adverse impacts of changes to accounting controls and reporting procedures, contingent liabilities or indemnification obligations, increased leverage and lack of access to available financing (including financing for the acquisition or refinancing of debt owed by us on a timely basis and on reasonable terms).

•Compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information, such as the Health Insurance Portability and Accountability Act of 1996 and the California Consumer Privacy Act in the U.S. and the General Data Protection Regulation requirements in Europe, including but not limited to those resulting from data security breaches.

•A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain due to challenges associated with integration of acquisitions, man-made or natural disasters, pandemic conditions, cybersecurity incidents or other causes.

•A major disruption in the operations of our manufacturing, accounting and financial reporting, research and development or distribution facilities due to the failure to perform by third-party vendors, including cloud computing providers or other technological problems, including any related to our information systems maintenance, enhancements or new system deployments, integrations or upgrades.

•A successful cybersecurity attack which could interrupt or disrupt our information technology systems, or those of our third-party service providers, or cause the loss of confidential or protected data.

18